Bayer Aktiengesellschaft Informations sur les dividendes
Bayer Aktiengesellschaft a un dividende annuel de 0.13 par action, avec un rendement de 0.00%. Le dividende est payé annuellement et la dernière date d'ex-dividende était le Apr 28, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.13
Apr 28, 2025
Fréquence des paiements
Taux de distribution
Annuellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Apr 28, 2025
$0.11
Apr 29, 2025
Apr 30, 2025
Apr 29, 2024
$0.11
Apr 30, 2024
May 2, 2024
May 2, 2023
$2.40
May 3, 2023
May 4, 2023
May 2, 2022
$2.00
May 3, 2022
May 4, 2022
Apr 28, 2021
$2.00
Apr 29, 2021
Apr 30, 2021
Apr 29, 2020
$2.80
Apr 30, 2020
May 4, 2020
Graphiques des dividendes
BAYZF Dividendes
BAYZF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Bayer Aktiengesellschaft et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Bayer Aktiengesellschaft ?
Quelle est la date ex-dividende pour BAYZF ?
À quelle fréquence Bayer Aktiengesellschaft verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que Bayer A.G. ?
Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 88,502 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.